These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32292562)

  • 21. Correlation of indoleamine-2,3-dioxigenase 1 inhibitory activity of 4,6-disubstituted indazole derivatives and their heme binding affinity.
    Tsujino H; Uno T; Yamashita T; Katsuda M; Takada K; Saiki T; Maeda S; Takagi A; Masuda S; Kawano Y; Meguro K; Akai S
    Bioorg Med Chem Lett; 2019 Oct; 29(19):126607. PubMed ID: 31431359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues.
    Ohta Y; Kubo H; Yashiro K; Ohashi K; Tsuzuki Y; Wada N; Yamamoto Y; Saito K
    J Physiol Sci; 2017 May; 67(3):361-372. PubMed ID: 27364617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.
    Bakmiwewa SM; Fatokun AA; Tran A; Payne RJ; Hunt NH; Ball HJ
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7641-6. PubMed ID: 23122865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1.
    Jiang S; Li H; Piao L; Jin Z; Liu J; Chen S; Liu LL; Shao Y; Zhong S; Wu B; Li W; Ren J; Zhang Y; Wang H; Jin R
    Aging (Albany NY); 2020 Jun; 12(12):11349-11363. PubMed ID: 32568737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
    Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
    Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative effects of oxygen on indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase of the kynurenine pathway.
    Dang Y; Dale WE; Brown OR
    Free Radic Biol Med; 2000 Feb; 28(4):615-24. PubMed ID: 10719243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of Reaction Intermediates in Tryptophan 2,3-Dioxygenase: A Comparison with Indoleamine 2,3-Dioxygenase.
    Basran J; Booth ES; Lee M; Handa S; Raven EL
    Biochemistry; 2016 Dec; 55(49):6743-6750. PubMed ID: 27951658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling Tryptophan/Indoleamine 2,3-Dioxygenase with Heme Superoxide Mimics: Is Ferryl the Key Intermediate?
    Mondal P; Wijeratne GB
    J Am Chem Soc; 2020 Jan; 142(4):1846-1856. PubMed ID: 31870154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2).
    Pei Z; Mendonca R; Gazzard L; Pastor R; Goon L; Gustafson A; VanderPorten E; Hatzivassiliou G; Dement K; Cass R; Yuen PW; Zhang Y; Wu G; Lin X; Liu Y; Sellers BD
    ACS Med Chem Lett; 2018 May; 9(5):417-421. PubMed ID: 29795752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition Mechanism of Indoleamine 2, 3-Dioxygenase 1 (IDO1) by Amidoxime Derivatives and Its Revelation in Drug Design: Comparative Molecular Dynamics Simulations.
    Liu X; Zhang Y; Duan H; Luo Q; Liu W; Liang L; Wan H; Chang S; Hu J; Shi H
    Front Mol Biosci; 2019; 6():164. PubMed ID: 32047753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.
    Austin CJ; Mailu BM; Maghzal GJ; Sanchez-Perez A; Rahlfs S; Zocher K; Yuasa HJ; Arthur JW; Becker K; Stocker R; Hunt NH; Ball HJ
    Amino Acids; 2010 Jul; 39(2):565-78. PubMed ID: 20140689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
    Röhrig UF; Majjigapu SR; Grosdidier A; Bron S; Stroobant V; Pilotte L; Colau D; Vogel P; Van den Eynde BJ; Zoete V; Michielin O
    J Med Chem; 2012 Jun; 55(11):5270-90. PubMed ID: 22616902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma.
    Terai M; Londin E; Rochani A; Link E; Lam B; Kaushal G; Bhushan A; Orloff M; Sato T
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32050636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure and mechanism of tryptophan 2,3-dioxygenase, a heme enzyme involved in tryptophan catabolism and in quinolinate biosynthesis.
    Zhang Y; Kang SA; Mukherjee T; Bale S; Crane BR; Begley TP; Ealick SE
    Biochemistry; 2007 Jan; 46(1):145-55. PubMed ID: 17198384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of Novel Inhibitors of Indoleamine 2,3-Dioxygenase 1 Through Structure-Based Virtual Screening.
    Zhang G; Xing J; Wang Y; Wang L; Ye Y; Lu D; Zhao J; Luo X; Zheng M; Yan S
    Front Pharmacol; 2018; 9():277. PubMed ID: 29651242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond.
    Platten M; Nollen EAA; Röhrig UF; Fallarino F; Opitz CA
    Nat Rev Drug Discov; 2019 May; 18(5):379-401. PubMed ID: 30760888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of Drosophila melanogaster tryptophan 2,3-dioxygenase reveals insights into substrate recognition and catalytic mechanism.
    Huang W; Gong Z; Li J; Ding J
    J Struct Biol; 2013 Mar; 181(3):291-9. PubMed ID: 23333332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
    Dolusić E; Larrieu P; Moineaux L; Stroobant V; Pilotte L; Colau D; Pochet L; Van den Eynde B; Masereel B; Wouters J; Frédérick R
    J Med Chem; 2011 Aug; 54(15):5320-34. PubMed ID: 21726069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tryptophan 2,3-dioxygenase inhibitory activities of tryptanthrin derivatives.
    Zhang S; Qi F; Fang X; Yang D; Hu H; Huang Q; Kuang C; Yang Q
    Eur J Med Chem; 2018 Dec; 160():133-145. PubMed ID: 30321802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity.
    Liu X; Shin N; Koblish HK; Yang G; Wang Q; Wang K; Leffet L; Hansbury MJ; Thomas B; Rupar M; Waeltz P; Bowman KJ; Polam P; Sparks RB; Yue EW; Li Y; Wynn R; Fridman JS; Burn TC; Combs AP; Newton RC; Scherle PA
    Blood; 2010 Apr; 115(17):3520-30. PubMed ID: 20197554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.